The heart and the brain within the broader context of wellness

Cleveland Clinic Journal of Medicine

Volumn 74, Issue SUPPL.1, 2007, Pages 56-58

  O'Donnell, Michael ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; HEALTH BEHAVIOR; HEALTH STATUS; HEART; HUMAN; LIFESTYLE; REVIEW;

BRAIN; HEALTH BEHAVIOR; HEALTH STATUS; HEART; HUMANS; LIFE STYLE;

EID: 34249853587     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.Suppl_1.S59     Document Type: Note

References (15)

1. McGinnis JM, Williams-Russo P, Knickman JR. The case for more active policy attention to health promotion. Health Aff (Millwood) 2002; 21:78-93.
2. Centers for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. MMWR Morb Mortal Wkly Rep 2002; 51:300-303.
3. National Center for Health Statistics. FastStats A to Z: Leading causes of death. Available at: www.cdc.gov/nchs/fastats/locd.htm.
4. Iestra JA, Kromhout D, van der Schouw YT, Grobbee DE, Boshuizen HC, van Staveren WA. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation 2005; 112:924-934.
5. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282:1523-1529.
6. Gould KL, Ornish D, Scherwitz L, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after longterm, intense risk factor modification. JAMA 1995; 274:894-901.
7. Sdringola S, Nakagawa K, Nakagawa Y, et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. J Am Coll Cardiol 2003; 41:263-272.
8. Kant AK, Schatzkin A, Graubard BI, Schairer C. A prospective study of diet quality and mortality in women. JAMA 2000; 283:2109-2115.
9. Hyland A, Vena C, Bauer J, et al. Cigarette smoking-attributable morbidity-United States, 2000. MMWR. Morbidity and Mortality Weekly Report 2003; 52:842-844.
10. Ott A, Slooter AJ, Hofman A, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998; 351:1840-1843.
11. Andel R, Crowe M, Pedersen NL, et al. Complexity of work and risk of Alzheimer's disease: a population-based study of Swedish twins. J Gerontol B Psychol Sci Soc Sci 2005; 60:P251-P258.
12. Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F. Physical activity, including walking, and cognitive function in older women. JAMA 2004; 292:1454-1461.
13. O'Donnell M. A simple framework to describe what works best: improving awareness, enhancing motivation, building skills, and providing opportunity. Am J Health Promo 2005; 20:1-12.
14. US Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System, 1986-2000. Available at: www.cdc.gov/brfss/.
15. Banks J, Marmot M, Oldfield Z, Smith JP. Disease and disadvantage in the United States and in England. JAMA 2006; 295:2037-2045.